Rethinking Clinical Trials

DECEMBER 20, 2023

CVD is the leading cause of mortality in women. Hospital admissions with acute coronary syndrome in women younger than 55 years increased 21% in 1995-1999 and 31% in 2010-2014. There are several strategies that will help increase diversity in CVD trials. The biggest barrier for CV medicine is the lack of women leaders in CV.

Clinical Trials 173

Clinical Trials Clinical Trials Trials Cardiology 173

XTalks

FEBRUARY 8, 2024

While direct-to-consumer (DTC) TV advertising remains a mainstay marketing strategy in pharma, ads have mostly been relegated to evening hours during certain programs for older audiences. At Astellas, we want all women to feel heard and their unique needs to be validated, which is why we are continuing to elevate this conversation.

Life Science 105

Life Science Marketing Branding Drugs 105

The Pharma Data

MAY 4, 2021

down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. mg) in women with uterine fibroids. mg) in healthy women ages 18-35 who are at risk for pregnancy. Chantix in the U.S.,

Vaccination 40

Vaccination Vaccine Production Sales 40